February 6, 2024

Holland & Knight Health Dose: February 6, 2024

Sarah Starling Crossan | Abigail Hemenway
Holland & Knight Health Dose

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • FY 2025 Appropriations Process to Begin March 11, 2024
  • Senators Release Discussion Draft of 340B Drug Pricing Legislation
  • Nominee for ASPE Assistant Secretary Approved by Senate Committee on Finance
  • House E&C Committee Hosts Healthcare Spending Hearing
  • Congress Shows Continued Interest in AI with Finance Hearing and Caucus Launch
  • Senate HELP Committee Hearing on Prescription Drug Pricing
  • House Hearings on Drug Shortages
  • House Budget Committee to Mark Up Bill Changing How CBO Scores Prevention
  • House Oversight Committee Marks Up PBM Reform Legislation
  • Retirements
  • CMS Releases Proposed Payment Updates for 2025 Medicare Advantage and Part D Programs
  • CMS Releases Draft CY 2025 Part D Redesign Program Instructions, Seeking Comment
  • CMS Makes Initial Offers in Medicare Drug Price Negotiation Program; Announces Availability of New Information and Resources
  • CMS Releases ICRs Related to Implementation of IRA Medicare Prescription Drug Provisions
  • Medicare Drug Price Negotiation Program Patient-Focused Listening Sessions Transcripts Available
  • SAMHSA Issues Final Rule on Telehealth; Other Flexibilities for OUD Treatments
  • Sickle Cell Disease Announced as Initial Focus of CMMI's CGT Access Model
  • CMS Requests Vendor Engagement Ahead of 2025 eCQM Reporting/Performance Periods
  • CMS Announces Increased Participation in ACO Initiatives
  • BPC Urges FDA, CMS Collaboration to Streamline Coverage, Improve RWE
  • Final FDA Quality Management Rule Offers Two-Year Phase-In Period
  • AMA Panel Again Scraps Plan to Revamp Remote Monitoring CPT Codes
  • FDA Finalizes Guidance on Human Gene Therapy Products
  • CMS OMH Calls for Health Equity Proposals Closing Feb. 9, 2024
  • CDRH Extends Public Comment Deadline on Use of DHTs for Undiagnosed Diabetes Detection
  • AHRQ Announces National Webinar on Integrating Patient-Reported Outcomes into Practice
  • HHS Hosts First-Ever "Food is Medicine" Summit
  • Registration Open for FDA's Rare Disease Day 2024 Virtual Public Meeting

Read the full Health Dose »

Related Insights